Full Length Research Paper
References
|
Abdelmeguid NE, Chmaisse HN, Abou Zeinab NS (2010). Silymarin ameliorates cisplatin-induced hepatotoxicity in rats: histopathological and ultrastructural studies. Pakistan Journal of Biological Sciences 13 (10):463-479. |
|
|
Almpanis Z, Demonakou M, Tiniakos D (2016). Evaluation of liver fibrosis: Something old, something new.... Annals of Gastroenterology: Quarterly Publication of the Hellenic Society of Gastroenterology 29(4): 445. |
|
|
Altamirano-Barrera A, Barranco-Fragoso B, Mendez-Sanchez N (2017). Management strategies for liver fibrosis. Annals of Hepatology 16(1):48-56. |
|
|
Avizeh R, Najafzadeh H, Razijalali M, Shirali S (2010). Evaluation of prophylactic and therapeutic effects of silymarin and N-acetylcysteine in acetaminophen-induced hepatotoxicity in cats. Journal of Veterinary Pharmacology and Therapeutics 33(1):95-99. |
|
|
Chi X, Xiao H, Shi M, Cai G, Xie Y, Jiang J, Tian G, Wu S, Zhang C, Zhao P, and Chen J (2019). Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience. BMC Gastroenterol 19(1):88. |
|
|
Clichici S, Olteanu D, Filip A, Nagy A L, Oros A, and Mircea P A (2016). Beneficial Effects of Silymarin After the Discontinuation of CCl4-Induced Liver Fibrosis. Journal of Medicinal Food 19(8):789-797. |
|
|
El-Lakkany NM, Hammam OA, El-Maadawy WH, Badawy AA, Ain-Shoka AA, Ebeid FA (2012). Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis. Parasites and Vectors 5(1):9. |
|
|
Ezhilarasan D, Evraerts J, Sid B, Calderon P B, Karthikeyan S, Sokal E, Najimi M (2017). Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression. Hepatobiliary and Pancreatic Diseases International 16(1):80-87. |
|
|
French METAVIR Cooperative Study Group, and P. Bedossa (1994). Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 20 (1 Pt 1):15-20. |
|
|
Friedman SL (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. Journal of Biological Chemistry 275 (4):2247-2250. |
|
|
Friedman S L (2003). Liver fibrosis -- from bench to bedside. Journal of Hepatology 38:38-53. |
|
|
Gharbia S, Balta C, Herman H, Rosu M, Varadi J, Bacskay I, Cristian RE(2018).Enhancement of silymarin anti-fibrotic effects by complexation with hydroxypropyl (HPBCD) and randomly methylated (RAMEB) β-cyclodextrins in a mouse model of liver fibrosis. Frontiers in Pharmacology 9:883. |
|
|
Ghosh S, Sarkar A, Bhattacharyya S, Sil PC (2016). Silymarin Protects Mouse Liver and Kidney from Thioacetamide Induced Toxicity by Scavenging Reactive Oxygen Species and Activating PI3K-Akt Pathway. Frontiers in Pharmacology 7:481. |
|
|
Gu Y, Zhao J, Yao XM, Li Y (2010).Effects of bicyclol on immunological liver fibrosis in rats. Journal of Asian Natural Products Research 12(5):388-398. |
|
|
Gulamhusein AF, Hirschfield GM (2019). Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nature Reviews Gastroenterology and Hepatology, pp. 1-18. |
|
|
Han Y, Shi JP, Ma AL, Xu Y, Ding XD, Fan JG (2014).Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose. Clinical Drug Investigation 34(1):1-7. |
|
|
Hu QW, Liu GT (2006). Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action. Life Sciences 79(6):606-612. |
|
|
Jain A, Yadav A, Bozhkov AI, Padalko VI, Flora S JS (2011).Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats. Ecotoxicology and Environmental Safety 74(4):607-614. |
|
|
Li X, Zhou J, Chen S, Guan M, Wang Y, Zhao L, Zhou Y (2014). Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer. Journal of International Medical Research 42(4):906-914. |
|
|
Li Y, Dai GW, Liu GT (2001). Effect of bicyclol on acetaminophen-induced hepatotoxicity: energetic metabolism and mitochondrial injury in acetaminophen-intoxicated mice. Yao xue xue bao= Acta Pharmaceutica Sinica 36(10):723-726. |
|
|
Liu GT (2009). Bicyclol: a novel drug for treating chronic viral hepatitis B and C. Medicinal Chemistry 5(1):29-43. |
|
|
Liu X, Zhao M, Mi J, Chen H, Sheng L, Li Y (2017). Protective effect of bicyclol on anti-tuberculosis drug induced liver injury in rats. Molecules 22(4):524. |
|
|
Mallat A, Lotersztajn S (2013). Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. American Journal of Physiology-Cell Physiology 305(8):789-799 |
|
|
Mansour HM, Salama AAA, Abdel-Salam RM, Ahmed NA, Yassen NN, Zaki HF (2018). The anti-inflammatory and anti-fibrotic effects of tadalafil in thioacetamide-induced liver fibrosis in rats. Canadian Journal of Physiology and Pharmacology 96(12):1308-1317. |
|
|
Mastron JK, Siveen KS, Sethi G, Bishayee A (2015). Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review. Anticancer Drugs 26(5):475-486. |
|
|
Mu M, Zuo S, Wu RM, Deng KS, Lu S, Zhu JJ, Zou GL, Yang J, Cheng ML, Zhao XK (2018). Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-beta/Smad signaling pathway. Drug Design Development and Therapy 12(4):107-4115. |
|
|
Muthumani M, Prabu SM (2012). Silibinin potentially protects arsenic-induced oxidative hepatic dysfunction in rats. Toxicology Mechanisms and Methods 22(4):277-288. |
|
|
Naqiong W, Liansheng W, Zhanying H, Yuanlin G, Chenggang Z, Ying G, Jianjun L (2017). A multicenter and randomized controlled trial of bicyclol in the treatment of statin-induced liver injury. Medical science monitor: international Medical Journal of Experimental and Clinical Research 23:5760. |
|
|
Polyak SJ, Ferenci P, Pawlotsky JM (2013). Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection. Hepatology 57 (3):1262-1271. |
|
|
Saber S, Goda R, El-Tanbouly GS, Ezzat D (2018). Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis. International Immunopharmacology 64:340-349. |
|
|
Salam OMA, Sleem AA, Omara EA, Hassan NS (2009). Hepatoprotective effects of misoprostol and silymarin on carbon tetrachlorideâ€induced hepatic damage in rats. Fundamental and Clinical Pharmacology 23(2):179-188. |
|
|
Schutte K, Kipper M, Kahl S, Bornschein J, Gotze T, Adolf D, Arend J, Seidensticker R, Lippert H, Ricke J, Malfertheiner P (2013). Clinical characteristics and time trends in etiology of hepatocellular cancer in Germany. Digestion 87(3):147-159. |
|
|
Shaker E, Mahmoud H, Mnaa S (2010). Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food and Chemical Toxicology 48(3):803-806. |
|
|
Trautwein C, Friedman SL, Schuppan D, Pinzani M (2015). Hepatic fibrosis: concept to treatment. Journal of hepatology 62(1):15-24. |
|
|
Xie W, Shi G, Zhang H, Zhao G, Yu Z, Lang Z,Cheng J (2012).A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol. Hepatology International 6(2):441-448. |
|
|
Xu F, Liu C, Zhou D, Zhang L (2016). TGF-β/SMAD pathway and its regulation in hepatic fibrosis. Journal of Histochemistry and Cytochemistry 64(3):157-167. |
|
|
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Fukui H (2002). Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36(4):850-860. |
|
|
Zhang W, Hong R, Tian T (2013). Silymarin's protective effects and possible mechanisms on alcoholic fatty liver for rats. Biomolecules and Therapeutics 21(4):264-269. |
|
|
Zhen YZ, Li NR, He HW, Zhao SS, Zhang GL, Hao X F, Shao RG (2015). Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats. World Journal of Gastroenterology 21(23):7155. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
